Cancer Immunotherapy By Delivering Class II MHC Antigens Using a VLP Replicon
Technology
E-050-2014
Patent ID
E-050-2014-0-US-01
Country
US
Application Type
Patent Status
Abandoned
Patent Number
Publication Number
Application Number
61/916,394
IC
NCI
Date Filed
Date Issued
Patent PDF